Transplantation Market Growth by 2030: Continuous Technological Advancements in Transplantation Methods and Emergence of Tissue Banks in Developing Countries

The global transplantation market size is expected to reach USD 32.94 Billion in 2030 and register a revenue CAGR of 11.5% over the forecast period, according to the latest report by Reports and Data. Rising prevalence of various chronic diseases which can lead to organ failure and growing need for transplantation procedures across the globe are factors driving transplantation market revenue growth to a significant extent.
Access Free sample PDF Copy of the Report @ 
Transplantation is a process of removing an organ or tissue from the donor’s body and transplanting it into the recipient's body to replace a failed or damaged organ. Human organs such as kidney, lung, liver, pancreas, cornea, and skin can all be transplanted. Transplants aid in the restoration of a healthy body and help the patient live a healthy lifestyle. Technological advancements have helped in improving the success rate of transplants, and tissue transplants using advanced products are being performed at a significantly high rate. In addition, advanced software and systems make tissue and organ preservation more convenient.
The global market is expected to register robust revenue growth rate due to an increase in prevalence of various chronic diseases such as diabetes, cancer, heart disease, and renal disease, and an increase in incidence of burns and accidents, which can lead to organ failure. Organ transplants, tissue products, immunosuppressive drugs, and preservation solutions are in high demand. Market players are focusing on launching new products or developing new applications that combine patient’s existing organ and tissue procurement and preservation transplant services to meet transplantation needs.
Some Key Highlights From the Report
o    On February 2022, Hansa Biopharma AB, a Sweden-based company, announced that it has got authorization from French Haute Autorité de Santé (HAS) for Idefirix. The company will use Idefirix to desensitize highly sensitized patients undergoing kidney transplants.
o    Tissue product segment accounted for largest revenue share in 2021 due to an increase in demand for tissue and organ transplantation. Increasing prevalence of diseases including diabetes, cancer, cardiovascular disease, renal disease, and Alzheimer's disease has put a large population at risk of irreversible tissue damage, requiring a greater need for tissue transplantation, which is expected to continue to drive revenue growth of the segment.
o    Organ transplant segment accounted for largest revenue share in 2021. Organ transplantation is the process of removing an organ from a donor and transplanting it into the patient's body to replace an organ. An increasing number of organ transplants are being performed around the world as a result of the high rate of organ failure caused by chronic diseases and an unhealthy lifestyle, which is driving revenue growth of the segment.
o    Hospital segment accounted for largest revenue share in 2021 as a result of huge number of medical procedures and operations performed in hospitals. Most hospitals have accessibility to well-defined organ databases, which could be used to verify the supply of requested organs, allowing for quicker medical treatment.
o    Market in North America accounted for largest revenue share in 2021. Development and innovation in transplantation products and presence of vast biotechnology and medical product industries, as well as advanced healthcare facilities are factors driving revenue growth of transplantation market in this region.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Veloxis Pharmaceuticals, Inc., Abbott, Becton, Dickinson, and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc., CareDx, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc, Illumina, Inc., and QIAGEN.
To know more about the report, visit @ 
Transplantation Market Segmentation:
Product Outlook (Revenue, USD Billion; 2019–2030)
•    Tissue Products
•    Immunosuppressive Drugs
•    Preservation Solutions
Wound Type Outlook (Revenue, USD Billion; 2019–2030)
•    Organ Transplant
•    Tissue Transplant
Regional Outlook:
•    North America (U.S., Canada, Mexico)
•    Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
•    Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
•    Latin America (Brazil, Rest of LATAM)
•    Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ 
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Drug Discovery Informatics Market Size, Share & Analysis, By Function (Docking, Sequencing & Target Data Analysis, Library & Database Preparation), By Solution (Software, Services), By Application (Drug Development, Drug Discovery), By End-Use (Biotechnology), And By Region, Segment Forecast To 2027
Electronic Skin Market Size, Share & Analysis, By Product (Electronic Patches, Electronic Skinsuits), By Component (Photovoltaics Systems, Stretchable Circuits), By Sensors (Chemical Sectors, Tactile Sensors), By Application (Health Monitoring Systems), And Region, Segment Forecast To 2027
Proteomics Market Size, Share & Analysis, By Product (Instruments, Reagents, Services), By Technology (X-Ray Crystallography, Chromatography, Microarray Instruments, Protein Fractionation Systems, Electrophoresis, Spectroscopy), By Application (Clinical Diagnosis), And By Region Forecast To 2028
Respiratory Inhaler Devices Market Size, Share & Analysis, By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), By Mode of Operation (Digitally Operated Inhaler Devices), By Application (Chronic Obstructive Pulmonary Disease, Asthma), And By Region, Forecast To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs

Back to news